Sébastien Colette (GSK Vaccines)

Sébastien Colette joined GSK Vaccines in 2013, in the Cell and Viral Drug Substance team of the Technical Research and Development Department. He is focusing on upstream process development (viral- and recombinant protein-based production processes), optimization, and intensification at different development phases (early and late projects, process transfer to commercial facilities, life cycle projects). Sébastien holds a Master in Biomedical Sciences and a PhD in Biomedical and Pharmaceutical Sciences from University Catholique of Louvain, Brussels, Belgium (PhD devoted to the study of chronic gynecological inflammatory and estrogen-dependent disease: endometriosis).